EisenbergRL, BankWO, HedgcockMW.Renal failure after major angiography. JAMA1980; 68: 43–6.
2.
KumarS, HullJD, LathiS, CohenAJ, PletkaPG.Low incidence of renal failure after angiography. Arch Intern Med1981; 141: 1267–79.
3.
D'EliaJA, GleasonRE, AldayM, MalarickC, GodleyK, WarramJNephrotoxicity from angiographic contrast material. A prospective study. Am J Med1982; 72: 719–25.
4.
MasonRA, ArbeitLA, GironG.Renal dysfunction after arteriography. JAMA1985; 253: 1001–4.
5.
BernsAS.Nephrotoxicity of contrast media. Kidney Int1989; 36: 730–40.
6.
SwansonDP, ShettyPC, KastanDJ, RollinsN.Angiographic contrast media. In: SwansonDP, ChiltonHM, ThrallJH eds. Pharmaceuticals in medical imaging. New York: Macmillan Publishing, 1990: 1–77.
7.
PorterGA.Contrast medium-associated nephropathy. Recognition and management. Invest Radiol1993; 28(suppl 4):S11–8.
8.
SchwabSJ, HlatkyMA, PieperKS, DavidsonCJ, MorrisKG, SkeltonTNContrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent. N Engl J Med1989; 320: 149–53.
9.
SteinbergEP, MooreRD, BrinkerJA, FishmanEK, PoweNR, GrazianoSLNephrotoxicity of low osmolality contrast media versus high osmolality media. Invest Radiol1991; 26(suppl 1):S86.
10.
BarrettBJ, ParfreyPS, VavasourHM, McDonaldJ, KentG, HeffertonDContrast nephropathy in patients with impaired renal function: high versus low osmolar media. Kidney Int1992; 41: 1274–9.
11.
MooreRD, SteinbergEP, PoweNR, BrinkerJA, FishmanEK, GrazianoSNephrotoxicity of high-osmolality versus low-osmolality contrast media: randomized clinical trial. Radiology1992; 182: 649–55.
12.
BarrettBJ, CarlisleEJ.Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology1993; 188: 171–8.
13.
DietzJR, DavisJO, FreemanRH, VillarrealD, EcktenkampSF.Effects of intrarenal infusion of calcium entry blockers in anaesthetized dogs. Hypertension1983; 5: 482–8.
14.
EpsteinM.Calcium antagonists and the kidney: future therapeutic perspectives. Am J Kidney Dis1993; 21(suppl 3):16–25.
15.
BakrisGL, BurnettJC.A role for calcium in radiocontrast-induced reductions in renal hemodynamics. Kidney Int1985; 27: 465–8.
16.
DerayG, MartinezF, CacoubP, BaumelouB, BaumelouA, JacobsC.A role for adenosine calcium and ischemia in radiocontrast-induced intrarenal vasoconstriction. Am J Nephrol1990; 10: 316–22.
17.
NeumayerHH, JungeW, KufnerA, WenningA.Prevention of radiocontrast-media-induced nephrotoxicity by the calcium channel blocker nitrendipine: a prospective randomised clinical trial. Nephrol Dial Transplant1989; 4: 1030–6.
18.
RussoD, TestaA, VolpeLD, SansoneG.Randomised prospective study on renal effects of two different contrast media in humans: protective role of a calcium channel blocker. Nephron1990; 55: 254–7.
19.
CacoubP, DerayG, BaumelouA, JacobsC.No evidence for protective effects of nifedipine against radiocontrast-induced acute renal failure (letter). Clin Nephrol1988; 29: 215–6.
20.
HigginsCB, KuberM, SlutskyRA.Interaction between verapamil and contrast media in coronary arteriography: comparison of standard ionic and new nonionic media. Circulation1983; 68: 628–35.
21.
MorrisDL, WisneskiJA, GertzEW, WexmanM, AxelrodR, LangbergJJ.Potentiation by nifedipine and diltiazem of the hypotensive response after contrast angiography. J Am Coll Cardiol1985; 6: 785–91.
22.
WeisbergLS, KurnikPB, KurnikBRC. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int1994; 45: 259–65.
